Drug Side Effects
Search
VOGT-KOYANAGI-HARADA SYNDROME
VOGT-KOYANAGI-HARADA SYNDROME
was reported 112 times
VOGT-KOYANAGI-HARADA SYNDROME is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Nucleoside Analog Antiviral [EPC]
38
0.0004
1
Programmed Death Receptor-1 Blocking Antibody [EPC]
14
0.0001
2
CTLA-4-directed Blocking Antibody [EPC]
5
0.0001
3
Thyroid Hormone Synthesis Inhibitor [EPC]
1
0.0001
4
Carbonic Anhydrase Inhibitor [EPC]
1
0.0000
5
Bile Acid [EPC]
1
0.0000
6
Calcineurin Inhibitor Immunosuppressant [EPC]
4
0.0000
7
Polyene Antifungal [EPC]
1
0.0000
8
Dietary Cholesterol Absorption Inhibitor [EPC]
2
0.0000
9
Muscle Relaxant [EPC]
1
0.0000
10
Central alpha-2 Adrenergic Agonist [EPC]
1
0.0000
11
Dihydropyridine Calcium Channel Blocker [EPC]
4
0.0000
12
Prostaglandin Analog [EPC]
1
0.0000
13
Purine Antimetabolite [EPC]
1
0.0000
14
Acetylcholine Release Inhibitor [EPC]
1
0.0000
15
Thiazide Diuretic [EPC]
2
0.0000
16
Corticosteroid [EPC]
11
0.0000
17
Angiotensin Converting Enzyme Inhibitor [EPC]
1
0.0000
18
Kinase Inhibitor [EPC]
4
0.0000
19
Insulin Analog [EPC]
3
0.0000
20
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
21
Interferon beta [EPC]
1
0.0000
22
Mood Stabilizer [EPC]
1
0.0000
23
Anti-epileptic Agent [EPC]
1
0.0000
24
Vitamin D [EPC]
1
0.0000
25
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
26
Vitamin B12 [EPC]
1
0.0000
27
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
28
Vitamin C [EPC]
1
0.0000
29
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
30
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
31
Atypical Antipsychotic [EPC]
1
0.0000
32
Platelet Aggregation Inhibitor [EPC]
1
0.0000
33
Tumor Necrosis Factor Blocker [EPC]
1
0.0000